MILAN, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., an Italian pharmaceutical manufacturer, and EarlyHealth Group, a global pharmaceutical service provider, have announced the expansion of their strategic partnership to improve access to essential medicines across CARICOM member states and Mexico.

Building on more than 10 years of collaboration across the Middle East and Turkey, the two companies will now introduce key therapies in rheumatology diseases and cardiovascular care to support both public healthcare systems and private sector providers in the Caribbean and Mexico.

Francesco Lapeyre, Chief Operating Officer of Acarpia, commented, “We are proud to expand our partnership with EarlyHealth Group into CARICOM regions and Mexico. By working together to accelerate registration and supply of medicines that are frequently in shortage, we aim to close persistent access gaps and deliver measurable health impact for patients and providers.”

The expansion will be driven by EarlyHealth’s local entities, working hand in hand with government bodies and healthcare providers to streamline registrations, ensure regulatory alignment, and implement sustainable reimbursement strategies.

About EarlyHealth Group

EarlyHealth Group is a global pharmaceutical services company supporting clinical trials, early access programs, and market entry across 60 countries, with full-service operations in Latin America and the CARICOM region (www.early-health.com)

About Acarpia

Acarpia Farmaceutici S.r.l. is a pharmaceutical company headquartered in Milan, Italy, focused on enhancing consolidated and well-known products in the rheumatology and cardiovascular fields with the aim of generating new value for patients, physicians and the National Health Service through their repositioning and development (www.acarpia.com).

For media inquiries, please contact:
EarlyHealth Group Communications
press@early-health.com

This item of content is a press release from a third party provider who make no warranties or representations in connection with this content and therefore PA can make no warranties in respect of its use.

Tags

More Like This

EarlyHealth Group Acquires Corena to Drive $100M Growth in Türkiye’s Life Sciences Sector

Polpharma Group Calls for Urgent Action to Protect early equitable access to medicines for European patients

AC Health makes critical HIV care more accessible to Filipinos with USAID support

CHAPPER healthcare, AscellaHealth’s Global Pharmaceutical Distributor, Assumes Presidency of EUROPACCESS, Enhancing Access to Innovative Medicines

Ally Health and Acacium Group Partner to Revolutionise Tech-powered Clinical Care at Home

CHAPPER healthcare, AscellaHealth’s Global Pharmaceutical Distributor, Celebrates 50 Years of Global Pharmaceutical Excellence

EdgeCap-backed Comac Medical Group Expands with Acquisition of ILIFE Consulting, a French Early-phase Specialty CRO

Enteralia Bioscience SRL Acquires TFarma SRL